Literature DB >> 13780088

The effect of hyposensitization on the in vitro histamine release by specific antigen.

P P VANARSDEL, E MIDDLETON.   

Abstract

Entities:  

Keywords:  HAY FEVER/therapy; HISTAMINE/blood; POLLEN/extracts

Mesh:

Substances:

Year:  1961        PMID: 13780088     DOI: 10.1016/0021-8707(61)90103-4

Source DB:  PubMed          Journal:  J Allergy        ISSN: 0021-8707


× No keyword cloud information.
  8 in total

1.  IMMUNOLOGIC ASPECTS OF HUMAN REAGINIC ALLERGY: AN IN VITRO METHOD AND SOME APPLICATIONS.

Authors:  A G OSLER; L M LICHTENSTEIN; D A LEVY
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1965-02-16

2.  In vitro studies of human ragweed allergy: changes in cellular and humoral activity associated with specific desensitization.

Authors:  L M Lichtenstein; P S Norman; W L Winkenwerder; A G Osler
Journal:  J Clin Invest       Date:  1966-07       Impact factor: 14.808

Review 3.  Basophil histamine release. Assays and interpretation.

Authors:  I B Haydik; W S Ma
Journal:  Clin Rev Allergy       Date:  1988

Review 4.  Human reagins: appraisal of the properties of the antibody of immediate-type hypersensitivity.

Authors:  J A Flick
Journal:  Bacteriol Rev       Date:  1972-09

Review 5.  Allergic asthma in childhood.

Authors:  K Aas
Journal:  Arch Dis Child       Date:  1969-02       Impact factor: 3.791

6.  Immunologic and cellular changes accompanying the therapy of pollen allergy.

Authors:  D A Levy; L M Lichtenstein; E O Goldstein; K Ishizaka
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

7.  Allergen-specific subcutaneous immunotherapy in allergic asthma: immunologic mechanisms and improvement.

Authors:  Yousef A Taher; Paul A J Henricks; Antoon J M van Oosterhout
Journal:  Libyan J Med       Date:  2010-06-21       Impact factor: 1.657

8.  STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN.

Authors:  L M LICHTENSTEIN; A G OSLER
Journal:  J Exp Med       Date:  1964-10-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.